The Determination of the Biocompatibility of New Compositional Materials, including Carbamide-Containing Heterocycles of Anti-Adhesion Agents for Abdominal Surgery.
Nurdana KanashevaDmitry A FedorishinMaria V LyapunovaMikhail V BukterovOlga A KaidashAbdigali A BakibaevRakhmetulla YerkassovTogzhan MashanRimma NesmeyanovaVladimir V IvanovElena V UdutVera P TuguldurovaMargarita V SalinaVictor S MalkovAlexey S KnyazevPublished in: Molecules (Basel, Switzerland) (2024)
Due to traumatic injuries, including those from surgical procedures, adhesions occur in over 50% of cases, necessitating exclusive surgical intervention for treatment. However, preventive measures can be implemented during abdominal organ surgeries. These measures involve creating a barrier around internal organs to forestall adhesion formation in the postoperative phase. Yet, the effectiveness of the artificial barrier relies on considerations of its biocompatibility and the avoidance of adverse effects on the body. This study explores the biocompatibility aspects, encompassing hemocompatibility, cytotoxicity, and antibacterial and antioxidant activities, as well as the adhesion of blood serum proteins and macrophages to the surface of new composite film materials. The materials, derived from the sodium salt of carboxymethylcellulose modified by glycoluril and allantoin, were investigated. The research reveals that film materials with a heterocyclic fragment exhibit biocompatibility comparable to commercially used samples in surgery. Notably, film samples developed with glycoluril outperform the effects of commercial samples in certain aspects.
Keyphrases
- randomized controlled trial
- room temperature
- biofilm formation
- reduced graphene oxide
- minimally invasive
- spinal cord injury
- tissue engineering
- oxidative stress
- systematic review
- emergency department
- anti inflammatory
- pseudomonas aeruginosa
- staphylococcus aureus
- cystic fibrosis
- mass spectrometry
- cell adhesion
- percutaneous coronary intervention
- ionic liquid
- molecularly imprinted
- adverse drug
- high resolution
- solid phase extraction